Skip to main content

Salmonella Arthritis

  • Chapter
  • First Online:
Infections and the Rheumatic Diseases

Abstract

Salmonella spp. are gram-negative bacilli with a set of virulence factors that allow them to develop gastrointestinal tract involvement, manifested as severe diarrhoea and enteric fever syndrome, as well as extra-intestinal involvement. They have been associated with different infectious and non-infectious diseases. Since the early nineteenth century, typhoid fever has been a topic of debate. Clinical manifestations of Salmonella infections depend on the serovar involved; although most patients exhibit typical enteric fever syndrome or gastroenteritis, up to 2% develop Salmonella arthritis, which can manifest as reactive arthritis (ReA) or septic arthritis (SA).

ReA refers to immune-mediated joint damage with aseptic synovitis, usually with polyarticular involvement, whereas SA refers to the direct involvement of joint tissues by Salmonella bacilli, usually following haematogenous spread from a gastrointestinal focus and with a monoarticular compromise. Although it is infrequent, Salmonella arthritis is responsible for an important proportion of mortality and permanent disability. Therefore, awareness regarding these conditions must be raised among clinicians and researchers to improve their prevention, early diagnosis and adequate treatment.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 84.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 109.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 159.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Abbreviations

DMARDs:

Disease-modifying antirheumatic drugs

EFS:

Enteric fever syndrome

LPS:

Lipopolysaccharide

NSAIDs:

Non-steroidal anti-inflammatory drugs

RA:

Rheumatoid arthritis

ReA:

Reactive arthritis

SA:

Septic arthritis

SCV:

Salmonella-containing vacuole

SPI-1:

Salmonella pathogenicity island 1

References

  1. Akgul O, Ozgocmen S. Classification criteria for spondyloarthropathies. World J Orthop. 2011;2(12):107.

    Article  PubMed  PubMed Central  Google Scholar 

  2. Merola JF, Bermas B, Lu B, Karlson EW, Massarotti E, Schur PH, et al. Clinical manifestations and survival among adults with (SLE) according to age at diagnosis. Lupus. 2014;23(8):778–84.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  3. Goldenberg DL. Septic arthritis. Lancet. 1998;351(9097):197–202.

    Article  CAS  PubMed  Google Scholar 

  4. Singh AK, Aggarwal A, Chaurasia S, Misra R. Identification of immunogenic HLA-B∗27:05 binding peptides of Salmonella outer membrane protein in patients with reactive arthritis and undifferentiated spondyloarthropathy. J Rheumatol. 2013;40(2):173–85.

    Article  CAS  PubMed  Google Scholar 

  5. Tuompo R, Hannu T, Mattila L, Siitonen A, Leirisalo-Repo M. Reactive arthritis following Salmonella infection: a population-based study. Scand J Rheumatol. 2013;42(3):196–202.

    Article  CAS  PubMed  Google Scholar 

  6. Parry CM, Hien TT, Dougan G, White NJ, Farrar JJ, Minh HC, et al. Typhoid fever. N Engl J Med. 2002;347(22):1770–82.

    Article  CAS  PubMed  Google Scholar 

  7. Ledermann W. Una historia del bacilo de Eberth desde Junker hasta Germanier. Rev Chil infectología. 2003;20:58–61. Spanish

    Google Scholar 

  8. Eberth CJ. Die Organismen in den Organen bei Typhus abdominalis. Arch für Pathol Anat und Physiol und für Klin Med. 1880;81(1):58–74. German

    Google Scholar 

  9. Vartiainen J, Hurri L. Arthritis due to Salmonella Typhimurium. Acta Med Scand. 1964;175:771–6.

    Article  CAS  PubMed  Google Scholar 

  10. Morgan M, Forbes KJ, Gillespie S. Salmonella septic arthritis: a case report and review. J Infect. 1990;21:195–203.

    Article  CAS  PubMed  Google Scholar 

  11. David JR, Black RL. Salmonella arthritis. Medicine (Baltimore). 1960;39:385–403.

    Article  CAS  Google Scholar 

  12. Cohen JI, Bartlett JA, Corey GR. Extra-intestinal manifestations of salmonella infections. Medicine (Baltimore). 1987;66(5):349–88.

    Article  CAS  Google Scholar 

  13. Ajene AN, Fischer Walker CL, Black RE. Enteric pathogens and reactive arthritis: a systematic review of Campylobacter, Salmonella and Shigella-associated reactive arthritis. J Health Popul Nutr. 2013;31(3):299–307.

    Article  PubMed  PubMed Central  Google Scholar 

  14. Kaandorp CJ, Dinant HJ, van de Laar MA, Moens HJ, Prins AP, Dijkmans BA. Incidence and sources of native and prosthetic joint infection : a community based prospective survey. Ann Rheum Dis. 1997;56(8):470–5.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  15. Meijers KAE, Dijkmans BAC, Hermans J, van den Broek PJ, Cats A. Non-gonococcal infectious arthritis: a retrospective study. J Infect. 1987;14(1):13–20.

    Article  CAS  PubMed  Google Scholar 

  16. Gardner GC, Weisman MH. Pyarthrosis in patients with rheumatoid arthritis : a report of 13 cases and a review of the literature from the past 40 years. Am J Med. 1990;88(5):503–11.

    Article  CAS  PubMed  Google Scholar 

  17. Cook PP, Siraj DS. Infección y artritis. 10th ed. Kelley y Firestein. Tratado de reumatología. Elsevier Espa8#241;a, S.L.U.; 2018. p. 1876–90.

    Google Scholar 

  18. Gelman MI, Ward JR. Septic arthritis: a complication of rheumatoid arthritis. Radiology. 1977;122(1):17–23.

    Article  CAS  PubMed  Google Scholar 

  19. Dubost JJ, Soubrier M, De Champs C, Ristori JM, Bussière JL, Sauvezie B. No changes in the distribution of organisms responsible for septic arthritis over a 20 year period. Ann Rheum Dis. 2002;61(3):267–9.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  20. Maki-Ikola O, Leirisalo-Repo M, Kantele A, Toivanen P, Granfors K. Salmonella-specific antibodies in reactive arthritis. J Infect Dis. 1991;164(6):1141–8.

    Article  CAS  PubMed  Google Scholar 

  21. Noto Llana M, Sarnacki SH, Vázquez MV, Gartner AS, Giacomodonato MN, Cerquetti MC. Salmonella enterica induces joint inflammation and expression of Interleukin-17 in draining lymph nodes early after onset of enterocolitis in mice. Infect Immun. 2012;80(6):2231–9.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  22. Atkins BL, Bowler ICJW. The diagnosis of large joint sepsis. J Hosp Infect. 1998;40:263–74.

    Article  CAS  PubMed  Google Scholar 

  23. Jacques P, Elewaut D, Mielants H. Interactions between gut inflammation and arthritis/spondylitis. Curr Opin Rheumatol. 2010;22(4):368–74.

    Article  PubMed  Google Scholar 

  24. Giannella RA. Salmonella [Internet]. Medical microbiology. University of Texas Medical Branch at Galveston; 1996.

    Google Scholar 

  25. Su LH, Chiu CH. Salmonella: clinical importance and evolution of nomenclature. Chang Gung Med J. 2007;30(3):210–9.

    PubMed  Google Scholar 

  26. Gal-Mor O, Boyle EC, Grassl GA. Same species, different diseases: how and why typhoidal and non-typhoidal Salmonella enterica serovars differ. Front Microbiol. 2014;5:391.

    Article  PubMed  PubMed Central  Google Scholar 

  27. Fàbrega A, Vila J. Salmonella enterica serovar Typhimurium skills to succeed in the host: virulence and regulation. Clin Microbiol Rev. 2013;26(2):308–41.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  28. Jantsch J, Chikkaballi D, Hensel M. Cellular aspects of immunity to intracellular Salmonella enterica. Immunol Rev. 2011;240(1):185–95.

    Article  CAS  PubMed  Google Scholar 

  29. Ryan MP, O’Dwyer J, Adley CC. Evaluation of the complex nomenclature of the clinically and veterinary significant pathogen salmonella [Internet]. Vol. 2017.BioMed Research International. Hindawi Limited; 2017. p. 3782182.

    Google Scholar 

  30. Ochman H, Groisman EA. The evolution of invasion by enteric bacteria. Can J Microbiol. 1995;41(7):555–61.

    Article  CAS  PubMed  Google Scholar 

  31. Darwin KH, Miller VL. Molecular basis of the interaction of Salmonella with the intestinal mucosa. Clin Microbiol Rev. 1999;12(3):405–28.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  32. Wallis TS, Galyov EE. Molecular basis of Salmonella-induced enteritis. Mol Microbiol. 2000;36(5):997–1005.

    Article  CAS  PubMed  Google Scholar 

  33. Hensel M. Evolution of pathogenicity islands of Salmonella enterica. Int J Med Microbiol. 2004;294(2–3):95–102.

    Article  CAS  PubMed  Google Scholar 

  34. Hansen-Wester I, Hensel M. Salmonella pathogenicity islands encoding type III secretion systems. Microbes Infect. 2001;3(7):549–59.

    Article  CAS  PubMed  Google Scholar 

  35. Eichelberg K, Galán JE. Differential regulation of Salmonella typhimurium type III secreted proteins by pathogenicity island 1 (SPI-1)-encoded transcriptional activators InvF and HilA. Infect Immun. 1999;67(8):4099–105.

    CAS  PubMed  PubMed Central  Google Scholar 

  36. Rakeman JL, Bonifield HR, Miller SI. A hila-independent pathway to Salmonella typhimurium invasion gene transcription. J Bacteriol. 1999;181(10):3096–104.

    CAS  PubMed  PubMed Central  Google Scholar 

  37. Foster JW. Low pH adaptation and the acid tolerance response of Salmonella typhimurium. Crit Rev Microbiol. 1995;21(4):215–37.

    Article  CAS  PubMed  Google Scholar 

  38. Que JU, Casey SW, Hentges DJ. Factors responsible for increased susceptibility of mice to intestinal colonization after treatment with streptomycin. Infect Immun. 1986;53(1):116–23.

    CAS  PubMed  PubMed Central  Google Scholar 

  39. Thiennimitr P, Winter SE, Winter MG, Xavier MN, Tolstikov V, Huseby DL, et al. Intestinal inflammation allows Salmonella to use ethanolamine to compete with the microbiota. Proc Natl Acad Sci U S A. 2011;108(42):17480–5.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  40. Selsted ME, Miller SI, Henschen AH, Ouellette AJ. Enteric defensins: antibiotic peptide components of intestinal host defense. J Cell Biol. 1992;118(4):929–36.

    Article  CAS  PubMed  Google Scholar 

  41. Michetti P, Mahan MJ, Slauch JM, Mekalanos JJ, Neutra MR. Monoclonal secretory immunoglobulin A protects mice against oral challenge with the invasive pathogen Salmonella typhimurium. Infect Immun. 1992;60(5):1786–92.

    CAS  PubMed  PubMed Central  Google Scholar 

  42. Ledeboer NA, Frye JG, McClelland M, Jones BD. Salmonella enterica Serovar Typhimurium requires the Lpf, Pef, and Tafi Fimbriae for biofilm formation on HEp-2 tissue culture cells and chicken intestinal epithelium. Infect Immun. 2006;74(6):3156–69.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  43. Weening EH, Barker JD, Laarakker MC, Humphries AD, Tsolis RM, Bäumler AJ. The Salmonella enterica serotype Typhimurium lpf, bcf, stb, stc, std, and sth fimbrial operons are required for intestinal persistence in mice. Infect Immun. 2005;73(6):3358–66.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  44. Kohbata S, Yokoyama H, Yabuuchi E. Cytopathogenic effect of Salmonella typhi GIFU 10007 on M cells of murine ileal Peyer’s patches in ligated ileal loops: an ultrastructural study. Microbiol Immunol. 1986;30(12):1225–37.

    Article  CAS  PubMed  Google Scholar 

  45. Hughes EA, Galán JE. Immune response to Salmonella: location, location, location? Immunity. 2002;16(3):325–8.

    Article  CAS  PubMed  Google Scholar 

  46. Pace J, Hayman MJ, Galán JE. Signal transduction and invasion of epithelial cells by S. typhimurium. Cell. 1993;72(4):505–14.

    Article  CAS  PubMed  Google Scholar 

  47. Steele-Mortimer O. The Salmonella-containing vacuole: moving with the times. Curr Opin Microbiol. 2008;11(1):38–45.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  48. Kingsley RA, Humphries AD, Weening EH, De Zoete MR, Winter S, Papaconstantinopoulou A, et al. Molecular and phenotypic analysis of the CS54 island of Salmonella enterica serotype Typhimurium: identification of intestinal colonization and persistence determinants. Infect Immun. 2003;71(2):629–40.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  49. Carter JD, Hudson AP. Reactive arthritis: clinical aspects and medical management. Rheum Dis Clin N Am. 2009;35(1):21–44.

    Article  Google Scholar 

  50. Hannu T. Reactive arthritis. Best Pract Res Clin Rheumatol. 2011;25(3):347–57.

    Article  PubMed  Google Scholar 

  51. Rich E, Hook EW, Alarcon GS, Moreland LW. Reactive arthritis in patients attending an urban sexually transmitted diseases clinic. Arthritis Rheum. 1996;39(7):1172–7.

    Article  CAS  PubMed  Google Scholar 

  52. Granfors K, Jalkanen S, von Essen R, Lahesmaa-Rantala R, Isomaki O, Pekkola-Heino K, et al. Yersinia antigens in synovial-fluid cells from patients with reactive arthritis. N Engl J Med. 1989;320(4):216–21.

    Article  CAS  PubMed  Google Scholar 

  53. Granfors K, Jalkanen S, Mäki-Ikola O, Lahesmaa-Rantala R, Saario R, Toivanen A, et al. Salmonella lipopolysaccharide in synovial cells from patients with reactive arthritis. Lancet. 1990;335(8691):685–8.

    Article  CAS  PubMed  Google Scholar 

  54. Zhang Y, Gripenberg-Lerche C, Soderstrom KO, Toivanen A, Toivanen P. Antibiotic prophylaxis and treatment of reactive arthritis. Lessons from an animal model. Arthritis Rheum. 1996;39(7):1238–43.

    Article  CAS  PubMed  Google Scholar 

  55. Granfors K, Merilahti-Palo R, Luukkainen R, Möttönen T, Lahesmaa R, Probst P, et al. Persistence of Yersinia antigens in peripheral blood cells from patients with Yersinia enterocolitica O:3 infection with or without reactive arthritis. Arthritis Rheum. 1998;41(5):855–62.

    Article  CAS  PubMed  Google Scholar 

  56. Gracey E, Inman RD. Chlamydia-induced ReA: immune imbalances and persistent pathogens. Nat Rev Rheumatol. 2012;8(1):55–9.

    Article  CAS  Google Scholar 

  57. Anttonen K, Orpana A, Leirisalo-Repo M, Repo H. Aberrant TNF secretion by whole blood in healthy subjects with a history of reactive arthritis: time course in adherent and non-adherent cultures. Ann Rheum Dis. 2006;65(3):372–8.

    Article  CAS  PubMed  Google Scholar 

  58. Braun J, Yin Z, Spiller I, Siegert S, Rudwaleit M, Liu L, et al. Low secretion of tumor necrosis factor alpha, but no other Th1 or Th2 cytokines, by peripheral blood mononuclear cells correlates with chronicity in reactive arthritis. Arthritis Rheum. 1999;42(10):2039–44.

    Article  CAS  PubMed  Google Scholar 

  59. Yin Z, Braun J, Neure L, Wu P, Liu L, Eggens U, et al. Crucial role of interleukin-10/interleukin-12 balance in the regulation of the type 2 T helper cytokine response in reactive arthritis. Arthritis Rheum. 1997;40(10):1788–97.

    Article  CAS  PubMed  Google Scholar 

  60. Appel H, Neure L, Kuhne M, Braun J, Rudwaleit M, Sieper J. An elevated level of IL-10- and TGF β-secreting T cells, B cells and macrophages in the synovial membrane of patients with reactive arthritis compared to rheumatoid arthritis. Clin Rheumatol. 2004;23(5):435–40.

    Article  PubMed  Google Scholar 

  61. Singh AK, Misra R, Aggarwal A. Th-17 associated cytokines in patients with reactive arthritis/ undifferentiated spondyloarthropathy. Clin Rheumatol. 2011;30(6):771–6.

    Article  PubMed  Google Scholar 

  62. Singh R, Aggarwal A, Misra R. Th1/Th17 cytokine profiles in patients with reactive arthritis/undifferentiated spondyloarthropathy. J Rheumatol. 2007;34(11):2285–90.

    CAS  PubMed  Google Scholar 

  63. Shen H, Goodall JC, Hill Gaston JS. Frequency and phenotype of T helper 17 cells in peripheral blood and synovial fluid of patients with reactive arthritis. J Rheumatol. 2010;37(10):2096–9.

    Article  CAS  PubMed  Google Scholar 

  64. Bas S, Neff L, Viatte S, Vuillet M, Spenato U, Guerne PA, et al. Relationship between gamma-interferon and interleukin-17 in Chlamydia trachomatis reactive arthritis. Clin Exp Rheumatol. 2009;27(5):885–6.

    CAS  PubMed  Google Scholar 

  65. Eliçabe RJ, Di Genaro MS. Immunopathogenesis of reactive arthritis: role of the cytokines. World J Immunol. 2014;4(2):78.

    Article  Google Scholar 

  66. Goldenberg DL. Septic arthritis and other infections of rheumatologic significance. Rheum Dis Clin N Am. 1991;17(1):149–56.

    CAS  Google Scholar 

  67. Goldenberg DL, Reed JI. Bacterial arthritis. N Engl J Med. 1985;312(12):764–71.

    Article  CAS  PubMed  Google Scholar 

  68. Morgan DS, Fisher D, Merianos A, Currie BJ. An 18 year clinical review of septic arthritis from tropical Australia. Epidemiol Infect. 1996;117(3):423–8.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  69. Koch B, Lemmermeier P, Gause A, v Wilmowsky H, Heisel J, Pfreundschuh M. Demonstration of interleukin-1beta and interleukin-6 in cells of synovial fluids by flow cytometry. Eur J Med Res. 1996;1(5):244–8.

    CAS  PubMed  Google Scholar 

  70. Verdrengh M, Tarkowski A. Granulocyte-macrophage colony-stimulating factor in Staphylococcus aureus-induced arthritis. Infect Immun. 1998;66(2):853–5.

    CAS  PubMed  PubMed Central  Google Scholar 

  71. Osiri M, Ruxrungtham K, Nookhai S, Ohmoto Y, Deesomchok U. IL-1beta, IL-6 and TNF-alpha in synovial fluid of patients with non-gonococcal septic arthritis. Asian Pac J Allergy Immunol. 1998;16(4):155–60.

    CAS  PubMed  Google Scholar 

  72. Abdelnour A, Bremell T, Holmdahl R, Tarkowski A. Role of T lymphocytes in experimental Staphylococcus aureus arthritis. Scand J Immunol. 1994;39(4):403–8.

    Article  CAS  PubMed  Google Scholar 

  73. Roy S, Bhawan J. Ultrastructure of articular cartilage in pyogenic arthritis. Arch Pathol. 1975;99(1):44–7.

    CAS  PubMed  Google Scholar 

  74. Dineen PF, Harty JA, Dolan AM. Septic arthritis of the ankle due to Salmonella enteritidis. Foot Ankle Surg. 2011;17(2):e23–4.

    Article  PubMed  Google Scholar 

  75. Gupta MN, Sturrock RD, Field M. A prospective 2-year study of 75 patients with adult-onset septic arthritis. Rheumatology. 2001;40(1):24–30.

    Article  CAS  PubMed  Google Scholar 

  76. Meyer A, Chatelus E, Wendling D, Berthelot J-M, Dernis E, Houvenagel E, et al. Safety and efficacy of anti-tumor necrosis factor α therapy in ten patients with recent-onset refractory reactive arthritis. Arthritis Rheum. 2011;63(5):1274–80.

    Article  CAS  PubMed  Google Scholar 

  77. Bassetti M, Nicco E, Delfino E, Viscoli C. Disseminated Salmonella paratyphi infection in a rheumatoid arthritis patient treated with infliximab. Clin Microbiol Infect. 2010;16:84–5.

    Article  CAS  PubMed  Google Scholar 

  78. Pham OH, McSorley SJ. Protective host immune responses to Salmonella infection. Future Microbiol. 2015;10(1):101–10.

    Article  CAS  PubMed  Google Scholar 

  79. Pocock JM, Khun PA, Moore CE, Vuthy S, Stoesser N, Parry CM. Septic arthritis of the hip in a Cambodian child caused by multidrug-resistant Salmonella enterica serovar Typhi with intermediate susceptibility to ciprofloxacin treated with ceftriaxone and azithromycin. Paediatr Int Child Health. 2014;34(3):227–9.

    Article  CAS  PubMed  Google Scholar 

  80. Goldenberg DL. Infectious arthritis complicating rheumatoid arthritis and other chronic rheumatic disorders. Arthritis Rheum. 1989;32(4):496–502.

    Article  CAS  PubMed  Google Scholar 

  81. Warren CP. Arthritis associated with Salmonella infections. Ann Rheum Dis. 1970;29(5):483–7.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  82. Anand AJ, Glatt AE. Salmonella osteomyelitis and arthritis in sickle cell disease. Semin Arthritis Rheum. 1994;24(3):211–21.

    Article  CAS  PubMed  Google Scholar 

  83. Munigangaiah S, Khan H, Fleming P, Dolan MA. Septic arthritis of the adult ankle joint secondary to Salmonella enteritidis: acase report. J Foot Ankle Surg. 2011;50(5):593–4.

    Article  PubMed  Google Scholar 

  84. Hügle T, Schuetz P, Mueller B, Laifer G, Tyndall A, Regenass S, et al. Serum procalcitonin for discrimination between septic and non-septic arthritis. N Engl J Med. 2008;26(3):453–6.

    Google Scholar 

  85. Martínez-morillo M, Soria LM, Frutos AR, Segura BT, Holgado S, Olivé A. Artritis séptica de la articulación acromioclavicular : una localización atípica. 2014;10(1):37–42.

    Google Scholar 

  86. Barber CE, Kim J, Inman RD, Esdaile JM, James MT. Antibiotics for treatment of reactive arthritis: a systematic review and metaanalysis. J Rheumatol. 2013;40(6):916–28.

    Article  CAS  PubMed  Google Scholar 

  87. Leirisalo-Repo M. Reactive arthritis. Scand J Rheumatol. 2005;34(4):251–9.

    Article  CAS  PubMed  Google Scholar 

  88. Kvien TK, Gaston JSH, Bardin T, Butrimiene I, Dijkmans BAC, Leirisalo-Repo M, et al. Three month treatment of reactive arthritis with azithromycin: a EULAR double blind, placebo controlled study. Ann Rheum Dis. 2004;63(9):1113–9.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  89. Lauhio A, Leirisalo-Repo M, Lähdevirta J, Saikku P, Repo H. Double-blind, placebo-controlled study of three-month treatment with lymecycline in reactive arthritis, with special reference to Chlamydia arthritis. Arthritis Rheum. 1991;34(1):6–14.

    Article  CAS  PubMed  Google Scholar 

  90. Yli-Kerttula T, Luukkainen R, Yli-Kerttula U, Möttönen T, Hakola M, Korpela M, et al. Effect of a three month course of ciprofloxacin on the outcome of reactive arthritis. Ann Rheum Dis. 2000;59(7):565–70.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  91. Laasila K, Laasonen L, Leirisalo-Repo M. Antibiotic treatment and long term prognosis of reactive arthritis. Ann Rheum Dis. 2003;62(7):655–8.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  92. Rudwaleit M, Braun J, Sieper J. Treatment of reactive arthritis: a practical guide. BioDrugs. 2000;13(1):21–8.

    Article  CAS  PubMed  Google Scholar 

  93. Barth WF, Segal K. Reactive arthritis (Reiter’s syndrome). Am Fam Physician. 1999;60(2):499–503, 507

    CAS  PubMed  Google Scholar 

  94. Flores D, Marquez J, Garza M, Espinoza LR. Reactive arthritis: newer developments. Rheum Dis Clin N Am. 2003;29(1):37–59, vi

    Article  Google Scholar 

  95. Clegg DO, Reda DJ, Weisman MH, Cush JJ, Vasey FB, Schumacher HR, et al. Comparison of sulfasalazine and placebo in the treatment of reactive arthritis (Reiter’s syndrome). A Department of Veterans Affairs Cooperative Study. Arthritis Rheum. 1996;39(12):2021–7.

    Article  CAS  PubMed  Google Scholar 

  96. Flagg SD, Meador R, Hsia E, Kitumnuaypong T, Schumacher HR. Decreased pain and synovial inflammation after etanercept therapy in patients with reactive and undifferentiated arthritis: an open-label trial. Arthritis Rheum. 2005;53(4):613–7.

    Article  CAS  PubMed  Google Scholar 

  97. Coakley G, Mathews C, Field M, Jones A, Kingsley G, Walker D, et al. BSR & BHPR, BOA, RCGP and BSAC guidelines for management of the hot swollen joint in adults. Rheumatology. 2006;45(8):1039–41.

    Article  CAS  PubMed  Google Scholar 

  98. Mathews CJ, Kingsley G, Field M, Jones A, Weston VC, Phillips M, et al. Management of septic arthritis: a systematic review. Ann Rheum Dis. 2007;66(4):440–5.

    CAS  PubMed  PubMed Central  Google Scholar 

  99. Goldenberg DL, Brandt KD, Cohen AS, Cathcart ES. Treatment of septic arthritis: comparison of needle aspiration and surgery as initial modes of joint drainage. Arthritis Rheum. 1975;18(1):83–90.

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgment

The authors declare no conflicts of interest.

There is no financial support.

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2019 Springer Nature Switzerland AG

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Tobón, G.J., Garcia-Robledo, J.E., Nieto-Aristizábal, I. (2019). Salmonella Arthritis. In: Espinoza, L. (eds) Infections and the Rheumatic Diseases. Springer, Cham. https://doi.org/10.1007/978-3-030-23311-2_5

Download citation

Publish with us

Policies and ethics